It is Necessary to Increase the Training and Motivation of Primary Care Health Professionals in the Face Of Rare Diseases in Spain
DOI:
https://doi.org/10.14738/bjhmr.111.16353Keywords:
Rare Diseases, Medical Training, Primary Health Care, Clinical GeneticsAbstract
Background: Rare diseases (RDs) are defined as low prevalence diseases with great heterogeneity. Globally, they constitute an important public health problem. Most of them are incurable, chronic and have a great family impact. The objective of this study was to investigate the knowledge about RDs among primary care health professionals (137 doctors and 113 nurses) in our health area (Vigo, Spain). Methods: A total of 250 primary care health professionals, randomly chosen, completed an anonymous survey to evaluate their level of knowledge about aspects related to RDs. The survey contained a questionnaire (seven questions) related to basic aspects of rare diseases. Results: Primary care health professionals showed very poor knowledge about the impact of RDs on public health. There were no statistically significant differences when comparing the responses of doctors versus nurses in any of the responses obtained (p > 0.05). Conclusions: Among the main challenges facing RDs is shortening the diagnostic delay and providing comprehensive care. Primary care health professionals should play a key role, since they are the gateway to the health system. Unfortunately, the results of our survey reveal very poor knowledge about basic aspects of RDs. It is necessary to increase training and motivation if we want to improve the health care provided from primary care to patients with RDs.
References
Posada M, Alonso-Ferreira V, Sánchez EB. Enfermedades raras. 1a ed. Los Libros de la Catarata; 2016)
Avellaneda Fernández A, Pérez Martín A, Pombo Allés G, Gutiérrez Delgado E, Izquierdo Martínez M. Grupo de Trabajo de Enfermedades Raras de Semergen. Percepción de las enfermedades raras por el médico de atención primaria [Perception of rare diseases by the primary care physicians]. Semergen. 2012; 38(7):421-431.
Nguengang Wakap, S., Lambert, DM, Olry, A. et al. Estimación de la prevalencia puntual acumulada de enfermedades raras: análisis de la base de datos Orphanet. Eur J Hum Genet 2020; 28: 165-173.
FEGEREC. Federación Gallega de Enfermedades Raras e Crónicas. https://fegerec.es/enfermedades-rarasque-son-es.html.
Online Mendelian Inheritance in Man: htpps://www.omim.orge/.
https://who.int/standards/classifications/frequently-asked-questions/rare-diseases.
https://rarediseases.info.nih.gov/about.
https://eurordis.org/information-support/what-is-a-rare-disease/
Posada M, Izquierdo M, Ferrari, MJ, Avellaneda A, Andrés P, et al. Plan de Acción de la UE y del Estado Español sobre enfermedades de baja prevalencia. . Boletín del Real Patronato sobre Discapacidad. 2002; 53:25-29.
Posada de la Paz M, M. GRF. Enfermedades raras: concepto, epidemiología, situación actual y perspectivas futuras. . Aten Primaria 2010; 42:169-172.
García-Ribes M. El diagnóstico de las enfermedades raras desde la consulta de Atención Primaria: desmontando el mito (The diagnosis of rare diseases in the primary care clínic: Dismantling the myth). Aten Primaria 2013; 45(7):338-340). 178
Smith CS, Paauw DS. When you hear hoof beats: four principles for separating zebras from horses. J Am Board Fam Pract 2000; 13:424-429.
Ortega Calvo M, Gómez-Chaparro Moreno JL, González-Meneses López A, Guillén Enríquez J, Varo Baena A, Fernández de la Mota E. Mapas conceptuales para el diagnóstico de las Enfermedades Raras en Atención Primaria. Aten Primaria 2012; 44(1):43-50).
Simpson JL, Rechitsky S, Kuliev A. Fertil Steril 2019; 112:622-630.
Pastor-Vivero, M. (2021). Spanish Cystic Fibrosis Registry: Report 2018. Spanish Cystic Fibrosis Society Registry Group. https://fibrosisquistica.org/wp-content/uploads/2021/04/Report2018-definitivo-4.pdf
Richards CS, Bradley LA, Amos J, et al. Standards and guidelines for CFTR mutation testing. Genet Med. 2002:4:379-391.
Watson, Michael S., et al. Cystic fibrosis population carrier screening: 2004 revision of American College of Medical Genetics mutation panel. Genetics in medicine 2004; 6:387-391.
Updated recommendations for CFTR carrier screening: A position statement of the American College of Medical Genetics and Genomics (ACMG) Genetics in Medicine 2023; 25: 100867
J.L. Deignan, C. Astbury, G.R. Cutting, et al. CFTR variant testing: a technical standard of the American College of Medical Genetics and Genomics (ACMG). Genet Med, 2020; 22(8): 1288-1295, 10.1038/s41436-020-0822-5
Emery J, Hayflick S. The challenge of integrating genetic medicine into primary care. BMJ. 2001; 322:1027-1030.
Ferreira RL, do Nascimento IJB, de Almeida VIA, de Oliveira VRL, Marangne LG, Dos Santos Gameleira F, Dutra TRC, de Oliveira Santos D, Dias Afonso MP, Dos Santos PEA, de Oliveira HN, Vilhena Dias FM. The utilisation of primary health care system concepts positively impacts the assistance of patients with rare diseases despite limited knowledge and experience by health care professionals: A qualitative synopsis of the evidence including approximately 78 000 individuals. J Glob Health. 2023 Aug 4; 13:04030. doi: 10.7189/jogh.13.04030. PMID: 37539555; PMCID: PMC10401310.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Susana Portela Pérez, Lucía Cameselle-Cortizo, Teresa Calheiros Cruz, Vanesa Rodríguez-Fernández, Jorge F Cameselle-Teijeiro
This work is licensed under a Creative Commons Attribution 4.0 International License.
